Douglas Corley to Bone Density Conservation Agents
This is a "connection" page, showing publications Douglas Corley has written about Bone Density Conservation Agents.
Connection Strength
0.684
-
Risk of complete atypical femur fracture with Oral bisphosphonate exposure beyond three years. BMC Musculoskelet Disord. 2020 Dec 03; 21(1):801.
Score: 0.168
-
Atypical femur fracture incidence in women increases with duration of bisphosphonate exposure. Osteoporos Int. 2019 Dec; 30(12):2515-2520.
Score: 0.154
-
Persistence with weekly alendronate therapy among postmenopausal women. Osteoporos Int. 2006; 17(6):922-8.
Score: 0.121
-
Oral Bisphosphonate Exposure and the Risk of Upper Gastrointestinal Cancers. PLoS One. 2015; 10(10):e0140180.
Score: 0.117
-
Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure. J Oral Maxillofac Surg. 2010 Feb; 68(2):243-53.
Score: 0.077
-
Clinical correlates of atypical femoral fracture. Bone. 2012 Jul; 51(1):181-4.
Score: 0.046